journal article·2022-09

NIR/MRI‐Guided Oxygen‐Independent Carrier‐Free Anti‐Tumor Nano‐Theranostics

Di Gao, Yupeng Shi, Jiahua Ni, Shuojia Chen, Ying Wang, Bin Zhao, Manli Song, Xiaoqing Guo, Xuechun Ren, Xingcai Zhang, Zhongmin Tian, Zhe Yang

Small· Volume 18· Issue 36
Publisher page

Abstract

Abstract Imaging‐guided photothermal therapy (PTT)/photodynamic therapy (PDT) for cancer treatment are beneficial for precise localization of the malignant lesions and combination of multiple cell killing mechanisms in eradicating stubborn thermal‐resistant cancer cells. However, overcoming the adverse impact of tumor hypoxia on PDT efficacy remains a challenge. Here, carrier‐free nano‐theranostic agents are developed (AIBME@IR780‐APM NPs) for magnetic resonance imaging (MRI)‐guided synergistic PTT/thermodynamic therapy (TDT). Two IR780 derivatives are synthesized as the subject of nanomedicine to confer the advantages for the nanomedicine, which are by feat of amphiphilic IR780‐PEG to enhance the sterical stability and reduce the risk from reticuloendothelial system uptake, and IR780‐ATU to chelate Mn2+ for T1‐weighted MRI. Dimethyl 2,2′‐azobis(2‐methylpropionate) (AIBME), acting as thermally decomposable radical initiators, are further introduced into nanosystems with the purpose of generating highly cytotoxic alkyl radicals upon PTT launched by IR780 under 808 nm laser irradiation. Therefore, the sequentially generated heat and alkyl radicals synergistically induce cell death via synergistic PTT/TDT, ignoring tumor hypoxia. Moreover, these carrier‐free nano‐theranostic agents present satisfactory biocompatibility, which could be employed as a powerful weapon to hit hypoxic tumors via MRI‐guided oxygen‐independent PTT and photonic TDT.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Cancer, Hypoxia, and Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

The Key Laboratory of Biomedical Information Engineering of Ministry of Education School of Life Science and Technology Xi'an Jiaotong University Xi'an 710049 P. R. China

Henan Key laboratory of Functional Magnetic Resonance Imaging and Molecular Imaging Department of MRI The First Affiliated Hospital of Zhengzhou University Zhengzhou 450000 P. R. China

School of Engineering Massachusetts Institute of Technology Cambridge MA 02139 USA

John A. Paulson School of Engineering and Applied Sciences Harvard University Cambridge MA 02138 USA

Department of Epidemiology Shaanxi Provincial Tumor Hospital Xi'an 710061 P. R. China

Research Center of Life Science Research Institute of Xi'an Jiaotong University Zhejiang 311200 P. R. China

Funding

National Natural Science Foundation of China · China Postdoctoral Science Foundation · Natural Science Foundation of Shaanxi Province · Natural Science Foundation of Zhejiang Province

References (77)

Show source-provided references
1. 10.1021/acsnano.0c0911510.1021/acsnano.0c09115 ↗
2. 10.1038/s41551-017-0131-810.1038/s41551-017-0131-8 ↗
3. 10.1038/s41467-021-25075-810.1038/s41467-021-25075-8 ↗
4. 10.1002/adfm.20200802010.1002/adfm.202008020 ↗
5. 10.1093/nsr/nwab17210.1093/nsr/nwab172 ↗
6. 10.1016/j.mtadv.2021.10015010.1016/j.mtadv.2021.100150 ↗
7. 10.1021/acs.nanolett.0c0081710.1021/acs.nanolett.0c00817 ↗
8. 10.1021/acs.nanolett.9b0063010.1021/acs.nanolett.9b00630 ↗
9. 10.1016/j.addr.2020.11.00110.1016/j.addr.2020.11.001 ↗
10. 10.1126/sciadv.aba568410.1126/sciadv.aba5684 ↗
11. 10.1080/02656736.2020.182583610.1080/02656736.2020.1825836 ↗
12. 10.1016/j.mtbio.2019.10003510.1016/j.mtbio.2019.100035 ↗
13. 10.1038/s41551-016-000810.1038/s41551-016-0008 ↗
14. 10.1016/j.actbio.2020.08.04210.1016/j.actbio.2020.08.042 ↗
15. 10.1021/acsnano.0c0772110.1021/acsnano.0c07721 ↗
16. 10.1021/acs.chemrev.8b0036310.1021/acs.chemrev.8b00363 ↗
17. 10.1038/s41585-019-0212-410.1038/s41585-019-0212-4 ↗
18. 10.1039/C8CS00618K10.1039/C8CS00618K ↗
19. 10.1039/C7CS00522A10.1039/C7CS00522A ↗
20. 10.1021/acsnano.1c0007610.1021/acsnano.1c00076 ↗
21. 10.1002/smll.20200339810.1002/smll.202003398 ↗
22. 10.3390/cells901006010.3390/cells9010060 ↗
23. 10.1016/j.nantod.2021.10117410.1016/j.nantod.2021.101174 ↗
24. 10.1016/j.biomaterials.2019.11930310.1016/j.biomaterials.2019.119303 ↗
25. 10.2147/CMAR.S17676310.2147/CMAR.S176763 ↗
26. 10.1038/s41571-020-0410-210.1038/s41571-020-0410-2 ↗
27. 10.1021/jacs.9b1155310.1021/jacs.9b11553 ↗
28. 10.1021/accountsmr.1c0003910.1021/accountsmr.1c00039 ↗
29. 10.1007/s40820-021-00689-110.1007/s40820-021-00689-1 ↗
30. 10.1021/jacs.1c0787510.1021/jacs.1c07875 ↗
31. 10.1039/C9CS00129H10.1039/C9CS00129H ↗
32. 10.1016/j.jconrel.2018.04.03010.1016/j.jconrel.2018.04.030 ↗
33. 10.1038/s41467-021-24961-510.1038/s41467-021-24961-5 ↗
34. 10.1002/anie.20180513810.1002/anie.201805138 ↗
35. 10.1126/sciadv.aaz057510.1126/sciadv.aaz0575 ↗
36. 10.1038/s41427-021-00303-110.1038/s41427-021-00303-1 ↗
37. 10.1016/j.cej.2020.12720010.1016/j.cej.2020.127200 ↗
38. Xiang H. · ACS Nano · 2019 · 13 · 2223
39. 10.1021/acsbiomaterials.0c0088910.1021/acsbiomaterials.0c00889 ↗
40. 10.1039/C8NH00340H10.1039/C8NH00340H ↗
41. 10.1073/pnas.201626811710.1073/pnas.2016268117 ↗
42. 10.1021/acsnano.0c0619010.1021/acsnano.0c06190 ↗
43. 10.1007/s40820-021-00616-410.1007/s40820-021-00616-4 ↗
44. 10.31635/ccschem.020.20200026610.31635/ccschem.020.202000266 ↗
45. 10.1002/smll.20190487010.1002/smll.201904870 ↗
46. 10.1002/adfm.20190343610.1002/adfm.201903436 ↗
47. 10.1021/acsnano.9b0598510.1021/acsnano.9b05985 ↗
48. 10.1038/s41467-021-21436-510.1038/s41467-021-21436-5 ↗
49. 10.4155/tde-2018-001310.4155/tde-2018-0013 ↗
50. 10.1021/acs.nanolett.8b0267010.1021/acs.nanolett.8b02670 ↗
51. 10.1016/j.jconrel.2019.10.01710.1016/j.jconrel.2019.10.017 ↗
52. 10.3390/ijms1910296310.3390/ijms19102963 ↗
53. 10.1039/C8SC04123G10.1039/C8SC04123G ↗
54. 10.1016/j.biomaterials.2017.09.01310.1016/j.biomaterials.2017.09.013 ↗
55. 10.1021/acs.molpharmaceut.8b0036710.1021/acs.molpharmaceut.8b00367 ↗
56. 10.1016/j.cej.2021.12917810.1016/j.cej.2021.129178 ↗
57. 10.1016/j.biomaterials.2020.12055710.1016/j.biomaterials.2020.120557 ↗
58. 10.1038/s41427-020-00256-x10.1038/s41427-020-00256-x ↗
59. 10.3390/nano811095210.3390/nano8110952 ↗
60. 10.4155/fdd-2019-000110.4155/fdd-2019-0001 ↗
61. 10.1016/j.actbio.2018.11.04910.1016/j.actbio.2018.11.049 ↗
62. 10.1016/j.biomaterials.2015.01.06910.1016/j.biomaterials.2015.01.069 ↗
63. 10.1016/j.pmatsci.2020.10076810.1016/j.pmatsci.2020.100768 ↗
64. 10.1016/j.ccr.2020.21358810.1016/j.ccr.2020.213588 ↗
65. 10.1039/C6DT04299F10.1039/C6DT04299F ↗
66. 10.1039/C7DT01801K10.1039/C7DT01801K ↗
67. 10.1016/j.addr.2011.05.00710.1016/j.addr.2011.05.007 ↗
68. 10.1002/adma.20210205410.1002/adma.202102054 ↗
69. 10.1271/bbb.8000210.1271/bbb.80002 ↗
70. 10.1021/acsami.9b1737510.1021/acsami.9b17375 ↗
71. 10.1002/anie.20170289810.1002/anie.201702898 ↗
72. 10.1016/j.bioactmat.2020.11.01610.1016/j.bioactmat.2020.11.016 ↗
73. 10.1016/j.vibspec.2004.03.00210.1016/j.vibspec.2004.03.002 ↗
74. 10.1021/acsnano.8b0352910.1021/acsnano.8b03529 ↗
75. 10.1186/s12951-020-0580-110.1186/s12951-020-0580-1 ↗
76. Wang J. · Nat. Rev. Mater. · 2021 · 19 · 1
77. 10.1038/s41578-018-0038-310.1038/s41578-018-0038-3 ↗